SMART anti-Tac-PE40 (PDL)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameSMART anti-Tac-PE40 (PDL)

Drug Alias NameSMART anti-Tac-PE40 (Protein Design Labs)anti-Tac-PE40 (PDL)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionInterleukin-2 receptor antagonists

TargetsInterleukin-2 receptor

Therapy Area/IndicationsRejection of organ transplantationGraft vs Host DiseaseAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPdl Biopharma Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPdl Biopharma Inc

Active IndicationsN/A

Inactive IndicationsRejection of organ transplantationGraft vs Host DiseaseAutoimmune Diseases

ATC CodeN/A